SCHEMBL22728305

SCHEMBL22728305

CC1(Cc2ccccc2F)CCN(C(=O)c2cccnc2-c2ccncc2)CC1

nearest known ligand 0.62

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ CYP46A1 Q9Y6A2 14/20 0.62
▸ CYP3A4 P08684 1/20 0.62
▸ CYP2C8 P10632 1/20 0.62
▸ CYP2C9 P11712 1/20 0.62
▸ CYP2C19 P33261 1/20 0.62
▸ PKM P14618 1/20 0.44
▸ ALDH1A1 P00352 4/20 0.42
▸ KDM4E B2RXH2 2/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ LMNA P02545 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ POLB P06746 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14848975 0.89 CYP46A1 (0.74) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL22728286 0.88 CYP46A1 (0.62) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL22728311 0.88 CYP46A1 (0.55) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL22728300 0.86 CYP46A1 (0.79) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL29453711 0.86 CYP46A1 (0.59) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL22719460 0.86 CYP46A1 (0.59) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL22728412 0.83 CYP46A1 (0.71) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL22728283 0.83 CYP46A1 (0.62) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL14849098 0.82 CYP46A1 (0.69) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL22728337 0.79 CYP46A1 (0.62) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020243027-A1 COMPOUNDS, COMPOSITIONS, AND METHODS OF USE SAGE THERAPEUTICS, INC. (US) 2020-12-03 — — WO disclosed
Send feedback